Viewing Study NCT02381535

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:10 PM
Ignite Modification Date: 2026-05-17 @ 12:45 PM
Study NCT ID: NCT02381535
Status: COMPLETED
Last Update Posted: 2025-02-11
First Post: 2015-03-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Onalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and Cisplatin
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 View
None Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 View
None Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and … View
None Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 View
None Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7 View
None Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7 View
None Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and … View
None Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7 View
None Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7 View
None Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7 View
None Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and … View
None Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7 View
Keywords: